1. Home
  2. ERH vs BSEM Comparison

ERH vs BSEM Comparison

Compare ERH & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Utilities and High Income Fund

ERH

Allspring Utilities and High Income Fund

N/A

Current Price

$10.21

Market Cap

90.5M

Sector

Finance

ML Signal

N/A

Logo BioStem Technologies Inc. Common Stock

BSEM

BioStem Technologies Inc. Common Stock

N/A

Current Price

$3.11

Market Cap

76.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ERH
BSEM
Founded
2004
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.5M
76.9M
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
ERH
BSEM
Price
$10.21
$3.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.1K
★ 133.7K
Earning Date
01-01-0001
11-12-2026
Dividend Yield
★ 8.85%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$87.68
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.16
$2.25
52 Week High
$13.07
$5.44

Technical Indicators

Market Signals
Indicator
ERH
BSEM
Relative Strength Index (RSI) 31.68 37.31
Support Level N/A $2.25
Resistance Level $11.69 $4.12
Average True Range (ATR) 0.15 0.50
MACD -0.02 -0.12
Stochastic Oscillator 22.02 6.97

Price Performance

Historical Comparison
ERH
BSEM

About ERH Allspring Utilities and High Income Fund

Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.

About BSEM BioStem Technologies Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Share on Social Networks: